MENU
+Compare
ALKS
Stock ticker: NASDAQ
AS OF
Jun 13 closing price
Price
$29.83
Change
-$0.95 (-3.09%)
Capitalization
4.55B

ALKS Alkermes plc Forecast, Technical & Fundamental Analysis

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas... Show more

Industry: #Biotechnology
ALKS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for ALKS with price predictions
Jun 13, 2025

Momentum Indicator for ALKS turns negative, indicating new downward trend

ALKS saw its Momentum Indicator move below the 0 level on June 13, 2025. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 95 similar instances where the indicator turned negative. In of the 95 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 63 cases where ALKS's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for ALKS turned negative on June 12, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at .

The 50-day moving average for ALKS moved below the 200-day moving average on June 06, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ALKS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

ALKS moved above its 50-day moving average on May 30, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for ALKS crossed bullishly above the 50-day moving average on May 20, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ALKS advanced for three days, in of 288 cases, the price rose further within the following month. The odds of a continued upward trend are .

ALKS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ALKS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.784) is normal, around the industry mean (62.115). P/E Ratio (8.902) is within average values for comparable stocks, (88.968). ALKS's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.913). Dividend Yield (0.000) settles around the average of (0.120) among similar stocks. P/S Ratio (2.779) is also within normal values, averaging (19.096).

View a ticker or compare two or three
ALKS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

ALKS is expected to report earnings to rise 200.15% to 39 cents per share on July 23

Alkermes plc ALKS Stock Earnings Reports
Q2'25
Est.
$0.39
Q1'25
Missed
by $0.18
Q4'24
Beat
by $0.30
Q3'24
Beat
by $0.01
Q2'24
Beat
by $0.04
The last earnings report on May 01 showed earnings per share of 12 cents, missing the estimate of 31 cents. With 2.21M shares outstanding, the current market capitalization sits at 4.55B.
A.I. Advisor
published General Information

General Information

a manufacturer of pharmaceutical products

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Biotechnology
Address
1 Burlington Road
Phone
+353 17728000
Employees
2100
Web
https://www.alkermes.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
FISR25.47-0.11
-0.43%
SPDR® SSGA Fixed Inc Sect Rotation ETF
RPV91.93-0.44
-0.48%
Invesco S&P 500® Pure Value ETF
AMZZ29.10-0.20
-0.68%
GraniteShares 2x Long AMZN Daily ETF
OCCI6.31-0.07
-1.10%
OFS Credit Company
VBK267.50-4.21
-1.55%
Vanguard Small-Cap Growth ETF

ALKS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ALKS has been loosely correlated with PAHC. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if ALKS jumps, then PAHC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALKS
1D Price
Change %
ALKS100%
-3.09%
PAHC - ALKS
35%
Loosely correlated
-2.37%
ESPR - ALKS
35%
Loosely correlated
-2.50%
VTRS - ALKS
34%
Loosely correlated
-1.87%
AMRX - ALKS
34%
Loosely correlated
-2.64%
COLL - ALKS
33%
Loosely correlated
-1.42%
More